nrct-101
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Feb 25, 2023 (NCT05683249)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06673368 | Phase 2 | Nov 30, 2024 | Neurocentria, Inc. |
| NCT06215144 | Phase 2/Phase 3 (Phase 3) | Jan 25, 2024 | Neurocentria, Inc. |
| NCT05683249 | Phase 2/Phase 3 (Phase 3) | Feb 25, 2023 | Neurocentria, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neurocentria, Inc. | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1